ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

No reported Accounts Payables figures are available to summarize.

Accounts Payables history

Currency unavailable · from the cash flow

No Accounts Payables data reported for this period type.

Accounts Payables vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Accounts Payables for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SLNSilence Therapeutics plcLTM Mar 2026$5.6M USD——608.1%
WVEWave Life Sciences Ltd.LTM Mar 2026$4.81M USD+99.3%—6.7%
BNTCBenitec Biopharma Inc.LTM Mar 2026$4.66M USD-479.9%——
RNAAtrium Therapeutics, Inc.FY2025$3.73M USD——20.0%
PRMEPrime Medicine, Inc.LTM Mar 2026$2.66M USD+6.3%-26.0%66.0%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$2.19M USD-26.1%-1.7%4.8%
MGTXMeiraGTx Holdings plcLTM Mar 2026$1.34M USD-154.2%—1.7%
STOKStoke Therapeutics, Inc.LTM Mar 2026$829K USD-92.1%+460.3%2.6%
PRQRProQR Therapeutics N.V.LTM Mar 2026€0 EUR——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-59.1%-1.7%5.8%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.